

NSABP Members' Area
Password Protected - Access
Limited to NSABP Participating
Institutions Only
NSABP Foundation, Inc.
General NSABP Information
Financial Conflicts of Interest Policy
Contact the NSABP
Employment 
Clinical Trials Information
Clinical Trials Overview
Protocol Chart
Never Say Lost
Treatment Trials Information
Protocol B-51
Protocol B-52
Protocol B-53/S1207
Protocol B-55/BIG 6-13
Prevention Trials Information
Protocol P-1 - BCPT
Protocol P-2 - STAR
To report problems, ask
questions or make comments,
please send e-mail to:
Webmaster@nsabp.pitt.edu
|
Information on Protocol P-1 Breast Cancer Prevention Trial
Protocol P-1
A Clinical Trial to Determine the Worth of Tamoxifen for Preventing Breast Cancer
The Effect of Tamoxifen on Benign Breast Disease (12/10/2001)
Published Results (PDF format: for Viewing Only)*
Questions and Answers about the Breast Cancer Prevention Trial (PDF format: for Viewing Only)*
Questions and Answers about the European Prevention Trials
Press Release on the Breast Cancer Prevention Trial
Press Release in Spanish (PDF format: for Viewing Only)*
Participant Advisory Board (PAB) Biographies
* To view the PDF versions of the above press releases properly you will need Acrobat Reader,
which can be found here.
|